A comparison of three software platforms for automated ECG analysis

Journal of Pharmacological and Toxicological Methods

Volumn 60, Issue 1, 2009, Pages 28-38

  Chui, Ray W ^a   Vargas, Hugo M ^a  

^a AMGEN INC   (United States)

Author keywords

Automated ECG analysis; Beagle dogs; E 4031; Implanted telemetry; Method; Pattern recognition; QT interval; Software comparison

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; HEART MUSCLE POTENTIAL; MEDICAL INFORMATION SYSTEM; NONHUMAN; QT INTERVAL; QT PROLONGATION; TELEMETRY; VALIDATION PROCESS;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROCARDIOGRAPHY; MODELS, ANIMAL; PATTERN RECOGNITION, AUTOMATED; PIPERIDINES; PYRIDINES; REPRODUCIBILITY OF RESULTS; SOFTWARE; TELEMETRY;

ANIMALIA; CANIS FAMILIARIS;

EID: 68749084540     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2009.05.004     Document Type: Article

References (13)

1. Arrigoni C., and Crivori P. Assessment of QT liabilities in drug development. Cell Biology and Toxicology 23 (2007) 1-13
2. Chaves A.A., Zingaro G.J., Yordy M.A., Bustard K.A., O'sullivan S., Galijatovic-Idrizbegovic A., et al. A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and mk-499. Journal of Pharmacological and Toxicological Methods 56 (2007) 103-114
3. Chen X., Cass J.D., Bradley J.A., Dahm C.M., Sun Z., Kadyszewski E., et al. QT prolongation and proarrhythmia by moxifloxacin: Concordance of preclinical models in relation to clinical outcome. British Journal of Pharmacology 146 (2005) 792-799
4. Chui R.W., Fosdick A., Conner R., Jiang J., Bruenner B.A., and Vargas H.M. Assessment of two external telemetry systems (Physiojacket and JET) in beagle dogs with telemetry implants. Journal of Pharmacological and Toxicological Methods 60 (2009) 58-68
5. Gralinski M.R. The dog's role in the preclinical assessment of QT interval prolongation. Toxicologic Pathology 31 (2003) 11-16 Suppl
6. Hammond T.G., Carlsson L., Davis A.S., Lynch W.G., Mackenzie I., Redfern W.S., et al. Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: Results of an international survey. Cardiovascular Research 49 (2001) 741-750
7. Miyazaki H., Watanabe H., Kitayama T., Nishida M., Nishi Y., Sekiya K., et al. Qt prodact: Sensitivity and specificity of the canine telemetry assay for detecting drug-induced qt interval prolongation. Journal of Pharmacological Sciences 99 (2005) 523-529
8. Raunig D., Depasquale M.J., Huang C.H., Winslow R., and Fossa A.A. Statistical analysis of QT interval as a function of changes in RR interval in the conscious dog. Journal of Pharmacological and Toxicological Methods 46 (2001) 1-11
9. Roden D.M. Drug-induced prolongation of the QT interval. The New England Journal of Medicine 350 (2004) 1013-1022
10. Soloviev M.V., Hamlin R.L., Barrett R.M., Chengelis C.P., and Schaefer G.J. Different species require different correction factors for the QT interval. Cardiovascular Toxicology 6 (2006) 145-157
11. Tattersall M.L., Dymond M., Hammond T., and Valentin J.P. Correction of qt values to allow for increases in heart rate in conscious beagle dogs in toxicology assessment. Journal of Pharmacological and Toxicological Methods 53 (2006) 11-19
12. Toyoshima S., Kanno A., Kitayama T., Sekiya K., Nakai K., Haruna M., et al. Qt prodact: In vivo QT assay in the conscious dog for assessing the potential for qt interval prolongation by human pharmaceuticals. Journal of Pharmacological Sciences 99 (2005) 459-471
13. Van De Water A., Verheyen J., Xhonneux R., and Reneman R.S. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. Journal of Pharmacological Methods 22 (1989) 207-217